No Picture
News

Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Progress

SAN DIEGO, May 9, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet pa… […]

No Picture
News

BioMed Realty Launches The Second Phase At Gateway of Pacific – Expanding Its Landmark Campus At The Front Door Of San Francisco’s Premier Life Science Market

BioMed Realty also closes a $430 million financing on the first phase of Gateway of Pacific after executing a long-term lease with AbbVie Inc. for 480,000 square feet

SAN DIEGO, March 20, 2019 /PRNewswire/ — BioMed Realty, a Blackstone portfolio co… […]

No Picture
News

Southern California Philanthropists Richard and Melanie Lundquist Make $70 Million Unrestricted Gift to LA BioMed, Will Be Renamed Lundquist Institute

Funds will go toward recruiting top researchers and improving facilities in the South Bay region of LA County – one of the nation’s top ten biotech clusters

LOS ANGELES, Feb. 11, 2019 /PRNewswire/ — Southern California philanthropists Melanie and Ri… […]

No Picture
News

Qualigen obtains exclusive license to novel cancer drug technology from Advanced Cancer Therapeutics

Qualigen continues to strengthen its cancer drug technology portfolio

CARLSBAD, Calif., Dec. 18, 2018 /PRNewswire/ — Qualigen, Inc., and Advanced Cancer Therapeutics, LLC (ACT) today announced that Qualigen has licensed certain ACT patents, intellec… […]

No Picture
News

Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform

SAN DIEGO and FREISING, Germany, Dec. 18, 2018 /PRNewswire/ — Ajinomoto Bio-Pharma Services, a fully owned subsidiary of Ajinomoto Co. Inc. (TSE: 2802), and XL-protein GmbH, a privately owned German biopharmaceutical company, are pleased to announ… […]